Sigogne Mickael, Kanagaratnam Lukshe, Mora Caroline, Pierre Malika, Petrache Andreea, Marcus Claude, Fischbach Michel, Dramé Moustapha, Touré Fatouma
Division of Nephrology, University Hospital of Reims, Reims, France.
Division of Nephrology, University Hospital of Angers, Angers, France.
Kidney Int Rep. 2020 Apr 29;5(7):1007-1013. doi: 10.1016/j.ekir.2020.04.012. eCollection 2020 Jul.
Peritoneal dialysis (PD) is reported to be underused in the autosomal dominant polycystic kidney disease (ADPKD) population because doctors fear technical failure caused by reduced abdominal space and high intraperitoneal pressure (IPP).
We designed a multicenter retrospective study to be carried out in 15 French centers recruiting 60 patients with ADPKD treated with PD to identify factors associated with IPP. Inclusion criteria were start of PD between 2010 and 2017, available tomodensitometry, and IPP measurement in the first year of dialysis. The clinical and radiological data for each patient were reviewed by the same operator. Total kidney volume (TKV), liver volume, and the volume of the abdominal cavity were measured using contouring.
TKV and the volume of the abdominal cavity in women and men were, respectively, 2397 ml versus 3758 ml and 9402 ml versus 12,920 ml. In the univariate analysis, IPP was significantly and positively associated with body surface area ( = 0.0024), body mass index (BMI) ( < 0.0001), the volume of the abdominal cavity ( = 0.0005), and the volume of the dialysate infused in the peritoneal cavity (IPV) ( = 0.0108). In the multivariate analysis, only BMI was still significantly associated with IPP ( = 0.0004).
Our results identified BMI as the main factor linked to IPP in patients with ADPKD. Despite a reliable assessment of the volume of their organs we did not find any correlation between liver and kidney volumes and IPP. To our knowledge, this is the first study designed to identify factors associated with IPP in patients with ADPKD on PD.
据报道,腹膜透析(PD)在常染色体显性多囊肾病(ADPKD)人群中的使用不足,因为医生担心腹腔空间减小和高腹腔内压力(IPP)会导致技术失败。
我们设计了一项多中心回顾性研究,在15个法国中心开展,招募60例接受PD治疗的ADPKD患者,以确定与IPP相关的因素。纳入标准为2010年至2017年间开始PD治疗、可进行体层摄影术检查以及在透析第一年进行IPP测量。每位患者的临床和放射学数据由同一名操作人员进行审查。使用轮廓描绘法测量总肾体积(TKV)、肝脏体积和腹腔体积。
女性和男性的TKV及腹腔体积分别为2397 ml对3758 ml以及9402 ml对12920 ml。在单因素分析中,IPP与体表面积(P = 0.0024)、体重指数(BMI)(P < 0.0001)、腹腔体积(P = 0.0005)以及注入腹腔的透析液体积(IPV)(P = 0.0108)显著正相关。在多因素分析中,只有BMI仍与IPP显著相关(P = 0.0004)。
我们的结果确定BMI是ADPKD患者中与IPP相关的主要因素。尽管对其器官体积进行了可靠评估,但我们未发现肝脏和肾脏体积与IPP之间存在任何相关性。据我们所知,这是第一项旨在确定接受PD治疗的ADPKD患者中与IPP相关因素的研究。